Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money

76% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

  • Updates
  • artificial intelligence
  • autonomous vehicles
  • biotechnology
  • disruptive innovation
  • electric vehicles
  • semiconductors

Top Stories

Bayer and Google in drug discovery partnership

In today’s top stories, chipmaker TSMC reports a 78% revenue rise, Tata Motors reveals new electric vehicle portfolio models, and Bayer announces a partnership with Google that will deploy machine learning to aid drug discovery. Tesla emerges as one of Wall Street’s top five car stocks, and investment banks begin cutting jobs.

TSMC revenues up 78%

TSMC [TSM] reported revenues up 78% to NT$295.9bn ($9.7bn) in its Q4 earnings report on Thursday morning. Rumours spread on the previous day that TSMC was considering lowering prices on its 3nm chips, the cost of which have been high enough to prevent widespread adoption. Meanwhile, a bill passed in Taiwan last week could offer TSMC a 50% tax break for its operations within the country.

Tata Motors to expand EV portfolio

Tata Motors [TTM] will be expanding its EV portfolio, reported Reuters, in an effort to maintain its position as the top seller of EVs in India. Shailesh Chandra, managing director of Tata Motors Passenger Vehicles and its EV subsidiary acknowledged the range in the needs of buyers, saying, "Customer needs are getting very individualistic”. At India’s Auto Expo this week, the company showcased five EV models among a total of 12 new vehicles.

Bayer and Google announce ML drug discovery partnership

Bayer [BAYN.DE] announced a collaboration with Google [GOOGL] that will deploy Google Clouds Tensorflow Processing Units (TPUs) to accelerate drug discovery. TPUs running cutting-edge machine learning models (ML) and computationally intensive workloads [will] accelerate and scale Bayer's quantum chemistry calculations”, Wednesday's press release explained. Google Cloud CEO Thomas Kurian called drug discovery one of the most important applications for AI.”

Investment banks in brutalheadcount cuts

2023s selloffs have led BlackRock [BLK] to plan 500 job cuts globally, amounting to roughly 2.5% of its total workforce. Its assets under management fell 16% in the year to 30 September. Goldman Sachs [GS], meanwhile, began cuts of 3,200 employees, approximately 6.5% of its workforce last week, with many employees given just 30 minutes to leave after receiving no bonuses last year.

Tesla one of Wall Streets favourite car stocks

Tesla [TSLA] is one of Wall Streets five favourite car stocks according to analysis from Barrons, despite its share price falling over 65% in the last year. Sixty-four percent of analysts covering Tesla gave it a buyrating. The list includes a range of auto players, including parts suppliers and service providers. OReilly [ORLY], Lithia [LAD], Aptiv [APTV] and Copart [CPRT] comprised the top four, with 80% of analysts giving Copart a buyrating.

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

  • Includes free newsletter updates, unsubscribe anytime. Privacy policy

Latest articles